Journal article
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1
D Castiblanco, JA Rudd-Schmidt, T Noori, VR Sutton, YH Hung, TWH Flinsenberg, AW Hodel, ND Young, N Smith, D Bratkovic, H Peters, M Walterfang, JA Trapani, AJ Brennan, I Voskoboinik
Blood | Published : 2022
Abstract
Niemann-Pick disease type C1 (NP-C1) is a rare lysosomal storage disorder resulting from mutations in an endolysosomal cholesterol transporter, NPC1. Despite typically presenting with pronounced neurological manifestations, NP-C1 also resembles long-term congenital immunodeficiencies that arise from impairment of cytotoxic T lymphocyte (CTL) effector function. CTLs kill their targets through exocytosis of the contents of lysosome-like secretory cytotoxic granules (CGs) that store and ultimately release the essential pore-forming protein perforin and proapoptotic serine proteases, granzymes, into the synapse formed between the CTL and target cell. We discovered that NPC1 deficiency increases ..
View full abstractRelated Projects (2)
Grants
Awarded by European Molecular Biology Organization
Funding Acknowledgements
This work was supported by a fellowship and grants 1128587 (I.V., J.A.T.), 1059126 (I.V.) and 2011020 (I.V., M.W., A.J.B.) from the Australian National Health and Medical Research Council, research grant funding from the Australian NP-C Disease Foundation, Inc. (Y.H.H.), a University of Melbourne postgraduate scholarship (D.C.), and a European Molecular Biology Organization fellowship (T.W.H.F.).